| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.019 | 0.6 |